Cue Biopharma, Inc. Patent Application Trends in 2024

Cue Biopharma, Inc. patent applications in 2024

Error creating thumbnail: File missing

Top 10 Technology Areas

• C07K14/70539 (No explanation available)
  • Count: 14 patents
  • Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K14/55 (No explanation available)
  • Count: 11 patents
  • Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K38/00 (No explanation available)
  • Count: 8 patents
  • Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K2319/30 (No explanation available)
  • Count: 6 patents
  • Example: 20240181025. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
• C07K14/495 (No explanation available)
  • Count: 5 patents
  • Example: 20240101627. MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K9/0019 (No explanation available)
  • Count: 5 patents
  • Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K14/005 (No explanation available)
  • Count: 5 patents
  • Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K39/0008 (No explanation available)
  • Count: 4 patents
  • Example: 20240181025. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
• A61K35/17 (No explanation available)
  • Count: 4 patents
  • Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K14/4748 (No explanation available)
  • Count: 4 patents
  • Example: 20240199715. T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)

Emerging Technology Areas

• C40B40/10 (No explanation available)
  • Count: 1 patents
  • Example: 20240025964. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K16/2833 (No explanation available)
  • Count: 1 patents
  • Example: 20240025964. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K2039/645 (No explanation available)
  • Count: 1 patents
  • Example: 20240082411. T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
• C07K14/70575 (No explanation available)
  • Count: 1 patents
  • Example: 20240190933. Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
• A61K47/6425 (No explanation available)
  • Count: 1 patents
  • Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K47/642 (No explanation available)
  • Count: 1 patents
  • Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K39/001153 (No explanation available)
  • Count: 1 patents
  • Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• A61K39/001114 (No explanation available)
  • Count: 1 patents
  • Example: 20240189437. MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (Cue Biopharma, Inc.)
• C07K2318/20 (No explanation available)
  • Count: 1 patents
  • Example: 20240189403. Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)
• C07K2318/10 (No explanation available)
  • Count: 1 patents
  • Example: 20240189403. Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof simplified abstract (Cue Biopharma, Inc.)

Top Inventors

• Ronald D. Seidel, III of Boston MA (US) (12 patents)
• Rodolfo J. Chaparro of Cambridge MA (US) (12 patents)
• Ronald D. SEIDEL, III of Natick MA (US) (5 patents)
• John F. ROSS of Arlington MA (US) (5 patents)
• Chee Meng LOW of Cambridge MA (US) (4 patents)
• John F. Ross of Boston MA (US) (4 patents)
• Saso Cemerski of Boston MA (US) (4 patents)
• Chee Meng Low of Boston MA (US) (3 patents)
• Anish Suri of Boston MA (US) (1 patent)
• Raymond J. Moniz of Boston MA (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors